Mohamed S. ELSAKAYA, Monira T. İSMAİL, Mohamed N. HAMED, Hamdy A. HENDWAY, Magdy A. OMERA

Nebulized magnesium sulphate during acute exacerbation of asthma in adults after failure of Traditional treatment

The aim of this study is to evaluate the effectiveness of inhaled magnesium sulfate as a supplemental treatment in control of acute exacerbation of asthma in adults not responding to traditional treatment in the first hour. Patients who failed to respond to conventional measures randomly allocated to one of two groups: Group 1: In which patients received two doses of nebulized 300 mg MgSO4 /10 minutes apart & Group 2 (control group): in which patients received nebulized combination of (2.5 mg) salbutamol plus (250µg) ipratropium bromide up to two doses over one hour. Magnesium sulfate group showed better improvements than control group. The variables mostly predict SaO2 pre-post change. The only predictor variable was group (inhaled magnesium sulfate versus control); inhaled magnesium sulfate was associated with 1.9 greater change in SaO2 compared to control group (when all other variables were constant). Other variables were potential confounders but were not statistically significant. Inhaled MgSo4 to the traditional treatment (B2 agonist in combination with hydrocortisone) showed a better improvement in PEFR and SaO2 without recorded side effects compared to traditional treatment in control group. Magnesium sulphate (MgSO4) improves significantly the respiratory function of patients not responding to traditional treatment.

PDF

___

Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease (GBD) Cause Patterns. Seattle, WA: University of Washington; 2013 [8th May 2014]. Available from: www.healthmetricsandevaluation.org/gbd/ visualizations/gbd-cause-patterns.

Masoli, M, Fabian D, Holt S, et al, Global Initiative for Asthma (GINA) program: the global burden of asthma: executive summary of the GINA. Dissemination Committee report. Allergy. 2004;59(3):469-78.

Burt CW, McCaig LF, Trends in hospital emergency department utilization: United States, 1992-99. National Center for Health Statistics. Vital Health Stat. 2001;54(2):13.

Braman SS. The global burden of asthma. Chest J.2006;Suppl; 4S-12S:130

Strauss L, Hejal R, Galan G, et al, Observations on the effects of aerosolized albuterol in acute asthma. Am J Resp Crit Care Med. 1997;155(5):454-8.

Rodrigo C, Rodrigo G, Therapeutic response patterns to high and cumulative doses of salbutamol in acute severe asthma. Chest J. 1998;113(6):593-8.

Blitz M, Blitz S, Beasely R, et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database System Review J. 2005;128(1):337-44.

Mangat HS, D’Souza GA, Jacob MS. Nebulized magnesium sulphate versus nebulized salbutamol in acute bronchial asthma: a clinical trial. Eur Respir J. 1998;12(6):341–4.

Nannini LJ, Pendino JC, Corna RA. Magnesium sulfate as a vehicle for nebulized salbutamol in acute asthma. Am J Med. 2000;108(4):193-7.

Hughes R, Goldkam A, Masoli M. Use of isotonic nebulized magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: a randomized placebo-controlled trial. Lancet Respir Med. 2003;3(2):124-7.

Gandia F, Guénard H, Sriha B, et al. Inhaled magnesium sulphate in the treatment of bronchial hyper-responsiveness. Magnes Res. 2012;25(4):168-76.

Meral A, Coker M, Tanac R. Inhalation therapy with magnesium sulfate and salbutamol sulfate in bronchial asthma. Turk J Pediatr.n1996;38:169–75.

Bessmertny O, DiGregorio RV, Cohen H. A randomized clinical trial of nebulized magnesium sulfate in addition to albuterol in the treatment of acute mild-to-moderate asthma exacerbations in adults. Ann Emerg Med. 2002;39(2)585–91.

Aggarwal P, Sharad S, Handa R, et al. Comparison of nebulized magnesium sulphate and salbutamol combined with salbutamol alone in the treatment of acute bronchial asthma: a randomized study. Emerg Med J. 2006;23(5):358–62.

Powel C, Dwan K, Milan SJ, et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev. 2012;12:CD003898.

Goodacre S, Cohen J, Bradburn M, et al. Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a doubleblind, randomized controlled trial. Lancet Respir. Med. Jun. 2013;1(4):293300.